2017 ATS/ERS DLCO guidelines: What's new and why you should care
The development of the single-breath diffusion capacity test lead to understanding that shortness of breath in patients is not always attributable to flow or volume impairment, but could be caused by impairment in the lungs' primary function of gas exchange.1
The American Thoracic Society and the European Respiratory Society published updated DLCO guidelines in 2017. These new guidelines review the technical equipment specifications that new instrumentation should aim to meet or exceed.2 In addition, the updated guideline also makes recommendations that can be instituted in PFT labs today. These recommendations can have an impact on patient care and medical decision making, which will be the focus of the webcast.
Review the foundation of diffusion capacity testing, its clinical application, updated guidelines and how the measurement impacts doctor decision making.
This program is approved for one (1) hour of CRCE credit.
This webcast is approved by the American Association for Respiratory Care (AARC).
Questions and Answers
Read Dr. Christine Oropez’s answers to the frequently asked post-presentation questions about the webcast.
Already registered? View the webcast.
Identify sources of variability in DLCO measurement, including physiological and technical factors
Describe important changes in the 2017 technical standard for DLCO measurement compared to the prior guidelines released in 2005
Recognize the potential impact of test performance issues on clinical interpretation and medical decision making
2017 ATS/ERS DLCO Guidelines: What’s new and why you should care
This webinar reviews the foundation of diffusion capacity testing, its clinical application, updated guidelines and how the measurement impacts doctor decision making.